A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)

NCT00681538 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

572

Enrollment

INDUSTRY

Sponsor class

Conditions

Spasticity
Multiple Sclerosis

Interventions

DRUG: Sativex®
DRUG: Placebo

Sponsor

Jazz Pharmaceuticals